Petrobras, Ecopetrol complete Colombia Caribbean deepwater offshore exploration campaign with USD 1 billion investment
Bitget2026/10/05 15:20Petrobras, with Ecopetrol, completed a 2.5-year deepwater exploration campaign offshore Colombia’s Caribbean, drilling five wells. Program spending totaled about USD 1 billion, with Petrobras operating under the GUA-OFF-0 contract with Colombia’s hydrocarbons agency. Equity split set at 44.4% for Petrobras, 55.6% for Ecopetrol, strengthening the basin’s gas potential assessment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ecopetrol SA - Empresa Colombiana de Petroleos published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.
- Petrobras, with Ecopetrol, completed a 2.5-year deepwater exploration campaign offshore Colombia’s Caribbean, drilling five wells.
- Program spending totaled about USD 1 billion, with Petrobras operating under the GUA-OFF-0 contract with Colombia’s hydrocarbons agency.
- Equity split set at 44.4% for Petrobras, 55.6% for Ecopetrol, strengthening the basin’s gas potential assessment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gold Price Forecast: XAU/USD retraces gains and nears two-month lows at $4,104
BUZZ-Caribou shares plunge as company explores sale and cancels cancer project
October 7 - ** Caribou Biosciences (CRBU.O) shares fell 35.9% in pre-market trading to $0.72 ** Caribou Biosciences announced late Tuesday that it is exploring strategic options, including a potential sale, merger, or other transactions, to maximize shareholder value ** Caribou said it plans to halt development of its allogeneic CAR-T cell therapy programs, including vispa-cel for non-Hodgkin lymphoma and CB-011 for multiple myeloma ** Caribou also stated it will lay off employees and cut costs, with most layoffs expected to be completed by Q4 2026 ** As of June 30, the company held $113.8 millions in cash, cash equivalents, and marketable securities ** As of the previous trading day's close, the company's share price had dropped about 28% year-to-date (Note: For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them only for reader convenience. Reuters assumes no responsibility for any damages or losses resulting from the use of automated translation features.)
Australian Dollar: Neutral outlook inside tight range against US Dollar – UOB
Crypto prices
More
